Couples Rehab for Anxiety and Depression

Crisis resources: If you or your partner are in immediate danger, call 911. For mental health crises, call or text the 988 Suicide and Crisis Lifeline. For confidential addiction placement help, call Couples Rehab at (888) 500-2110 — available 24/7.

When anxiety or depression coexists with addiction, the two conditions fuel each other in a cycle that is nearly impossible to break without professional help. For couples, that cycle is doubled: each partner’s mental health symptoms can trigger the other’s substance use, and each person’s drinking or drug use can worsen the other’s anxiety and depression. The relationship itself becomes a shared environment that sustains both disorders simultaneously.

Couples Rehab is a national addiction treatment placement and referral network — not a treatment facility. Our placement team works with licensed providers across the United States that specialize in dual diagnosis treatment for couples, matching partners to programs equipped to address anxiety, depression, and substance use at the same time. We verify benefits and coordinate admission; we do not deliver treatment directly.

This page explains how anxiety and depression interact with addiction in couples, what integrated dual diagnosis treatment looks like in practice, how clinical teams determine whether joint treatment is appropriate, and how to begin the placement process today. You can also begin by taking the Couples Assessment or calling our care navigators directly at (888) 500-2110.

The Connection Between Anxiety, Depression, and Addiction

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), approximately 9.2 million adults in the United States live with a co-occurring mental health disorder and substance use disorder. Anxiety disorders and depression are the two most common mental health conditions found alongside addiction. The relationship between these conditions is not one-directional: substances do not simply cause anxiety and depression, nor do anxiety and depression simply cause substance use. The conditions interact, escalate each other, and over time become neurologically entangled.

How Anxiety and Substance Use Reinforce Each Other

Anxiety disorders — including generalized anxiety disorder (GAD), social anxiety disorder, and panic disorder — involve persistent, disproportionate fear responses that are not under voluntary control. Many people with untreated anxiety discover early in life that alcohol, benzodiazepines, cannabis, or opioids reduce the intensity of anxious symptoms. This reflects real pharmacological effects: alcohol and benzodiazepines act on GABA-A receptors, temporarily blunting the brain’s alarm system.

The problem is tolerance. The same dose provides less relief over time, requiring more substance to achieve the same calming effect. When the substance is absent, rebound anxiety — often more severe than the original baseline — floods back in. This rebound powerfully motivates continued use and, in the case of alcohol and benzodiazepines, can trigger dangerous withdrawal seizures without medical management.

For couples, the anxiety-substance cycle has a relational dimension. If one partner drinks to manage social anxiety before shared events, the other may begin to associate their partner’s calm presence with alcohol — enabling the pattern inadvertently. When the anxious partner becomes irritable or avoidant during rebound periods, relationship friction increases, which often deepens both partners’ stress and can accelerate substance use in both.

How Depression and Substance Use Interact

Major depressive disorder and persistent depressive disorder involve disruptions in mood, energy, motivation, sleep, appetite, and cognitive function that persist for weeks or months. The National Institute of Mental Health (NIMH) estimates that 21 million U.S. adults experienced at least one major depressive episode in the past year.

Substances are frequently used to manage depressive symptoms — alcohol for numbing, stimulants like cocaine or methamphetamine for temporary energy and euphoria, cannabis for emotional regulation. Over time, however, chronic alcohol use suppresses serotonin and dopamine function, worsening the neurochemical environment that depression operates in. Stimulant use produces intense dopamine release followed by a crash — a depressive trough that may be more severe than the person’s baseline depression.

In couples where one or both partners are depressed, emotional withdrawal from shared activities, persistent irritability, and loss of connection create distance. Partners may drink together to recapture closeness or self-medicate the loneliness of emotional disconnection, accelerating both the addiction and the depression in parallel.

When Both Partners Carry Co-Occurring Conditions

Research consistently reviewed by the National Institute on Drug Abuse (NIDA) finds that co-occurring mental health and substance use disorders each worsen the other’s course and prognosis when only one is treated. Treating addiction without addressing underlying anxiety or depression leaves the emotional driver of use intact. Treating depression or anxiety without addressing substance use leaves a powerful neurochemical disruptor in place that undermines psychiatric medications and behavioral therapies alike.

For couples in which both partners carry co-occurring diagnoses, the shared relational environment — common stressors, shared social networks, enabling patterns, and any relational trauma — becomes a treatment variable in itself. This is one of the strongest arguments for integrated dual diagnosis treatment in a couples-specialized program.

Dual Diagnosis: What It Means in a Couples Context

Dual diagnosis — also called co-occurring disorders — refers to the simultaneous presence of at least one mental health disorder and at least one substance use disorder. In a couples program, both partners may have dual diagnoses, or one may have a substance use disorder while the other has a mental health condition that has been worsened by living with an addicted partner. Either way, integrated treatment is the standard of care.

Dual diagnosis care requires that psychiatric assessment and pharmacological management be delivered alongside addiction medicine and behavioral therapy in a unified clinical framework. Programs that run separate mental health and addiction tracks without coordinating them miss the interaction between the conditions. The standard endorsed by SAMHSA and the American Society of Addiction Medicine (ASAM) is a single integrated treatment team addressing both disorders together.

Clinical Assessment Tools Used at Intake

During intake at a dual diagnosis program, clinicians use validated screening instruments to establish baseline severity for both psychiatric and substance use conditions. For couples seeking treatment for anxiety and depression alongside addiction, the assessment typically includes:

• PHQ-9 (Patient Health Questionnaire-9): A nine-item depression severity scale. Scores of 10 or above indicate clinically significant depression warranting treatment.
• GAD-7 (Generalized Anxiety Disorder 7-item scale): Measures anxiety severity and helps clinicians distinguish anxiety disorder from withdrawal-induced anxiety. Scores of 10 or above indicate moderate-to-severe anxiety.
• AUDIT (Alcohol Use Disorders Identification Test): Screens for alcohol use disorder severity and informs detox level-of-care decisions.
• CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised): Administered during alcohol detox to measure withdrawal severity and guide benzodiazepine dosing for seizure prevention.
• COWS (Clinical Opiate Withdrawal Scale): Measures opioid withdrawal severity and guides buprenorphine or methadone dosing under ASAM protocol.
• Columbia Suicide Severity Rating Scale (C-SSRS): Screens for suicidal ideation and behavior — critical given the elevated suicide risk in co-occurring depression and substance use disorder.

A key outcome of this assessment is determining whether the psychiatric symptoms are substance-induced (resolving with sobriety) or independent (requiring ongoing psychiatric treatment regardless of sobriety). Substance-induced anxiety and depression generally improve within days to weeks of detox; independent conditions require targeted pharmacological and behavioral intervention throughout and after treatment.

Can Couples Attend Dual Diagnosis Rehab Together?

In many cases, yes. Joint treatment for anxiety, depression, and addiction can be clinically appropriate and has documented relational and recovery benefits. Whether partners are placed together in the same program — or even the same clinical track — depends on a comprehensive clinical assessment that evaluates several factors.

Clinical Factors That Support Joint Dual Diagnosis Treatment

• Voluntary participation by both partners: Joint treatment is not effective as leverage to compel a reluctant partner into a program. Both partners must agree to participate.
• Safety screening for intimate partner violence (IPV): Admission teams screen for IPV or coercive control patterns. Active IPV is a contraindication for co-located treatment; safety must be established before joint programming can begin.
• Psychiatric acuity: If one partner presents with active suicidal ideation, psychosis, or a psychiatric emergency requiring acute stabilization, that partner may require a higher level of psychiatric care before entering shared couples programming.
• Compatible treatment needs: If one partner’s primary presentation is an anxiety disorder with minimal substance use and the other requires medical detox, the programs serving each partner may differ in the early phase before reuniting in shared programming.
• Relational factors driving mental health symptoms: Some anxiety and depression in couples has a relational origin — conflict, attachment injury, or trauma within the relationship. Couples-focused programming can address these directly; individual treatment cannot.

When these factors are favorable, the evidence for couples-based treatment is strong. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) recognizes Behavioral Couples Therapy (BCT) as an evidence-based approach that reduces drinking, improves relationship satisfaction, and enhances long-term sobriety outcomes compared to individual treatment alone.

Evidence-Based Treatments Used in Dual Diagnosis Couples Programs

Cognitive Behavioral Therapy (CBT)

CBT is the most extensively researched behavioral treatment for anxiety disorders, depression, and substance use disorders and forms the backbone of most dual diagnosis programs. CBT helps clients identify and restructure cognitive distortions — the automatic negative thoughts that sustain anxious and depressive patterns — while developing behavioral skills to interrupt those patterns without substances. In couples programming, joint CBT sessions help partners identify shared cognitive patterns that drive relational conflict and substance use, and practice interrupting each other’s cognitive spirals in ways that are supportive rather than enabling.

Dialectical Behavior Therapy (DBT)

DBT’s four skill modules — mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness — are highly applicable to couples managing co-occurring mental health and substance use conditions. Interpersonal effectiveness skills are particularly valuable for couples who have developed dysfunctional communication patterns around one or both partners’ anxiety or depression, helping partners make requests, set limits, and manage conflicts without escalating to substance use as a coping mechanism.

Behavioral Couples Therapy (BCT)

BCT involves structured relationship work that includes a daily sobriety contract, communication skills training, and shared activities designed to increase positive relationship interactions. Multiple randomized controlled trials show BCT produces better substance use outcomes and lower rates of domestic violence than individual treatment alone. When adapted for dual diagnosis couples, BCT incorporates psychoeducation about how mental health symptoms affect relationship dynamics so both partners can respond skillfully when psychiatric symptoms emerge.

EMDR and Trauma-Informed Care

Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based treatment for PTSD and trauma that also shows effectiveness for anxiety disorders and depression with a trauma component. Many couples seeking dual diagnosis care carry relational trauma — events within the relationship, or pre-existing trauma activated by the addiction or by the stress of living with an addicted partner. Trauma-informed care as a program framework recognizes that anxiety and depression are often downstream of trauma, and that confrontational addiction treatment models can retraumatize clients. Learn more about trauma therapy for couples in recovery and PTSD treatment for couples.

Psychiatric Medication Management

Integrated dual diagnosis programs include psychiatric prescribers who manage medications for anxiety and depression alongside addiction medicine. Key pharmacological considerations include:

• SSRIs and SNRIs (fluoxetine, sertraline, escitalopram, venlafaxine, duloxetine) are first-line pharmacological treatments for both depression and anxiety disorders. They carry no abuse potential and are compatible with medication-assisted treatment (MAT) for addiction.
• Benzodiazepines are effective for anxiety but carry significant dependence risk. In patients with alcohol or opioid use disorder, benzodiazepines are generally avoided outside of carefully monitored medical detox settings where CIWA-Ar scoring guides their use.
• Buspirone is a non-addictive anxiolytic appropriate for generalized anxiety disorder in patients with substance use disorder. It takes two to four weeks to become fully effective and does not carry benzodiazepine-type dependence risk.
• Buprenorphine and naltrexone — the primary MAT agents for opioid use disorder — are compatible with most psychiatric medications. Naltrexone is also FDA-approved for alcohol use disorder and can be used in patients with co-occurring depression or anxiety.

Withdrawal Symptoms and Mental Health: What to Expect During Detox

For couples entering dual diagnosis treatment who are also physically dependent on substances, the detox phase intersects directly with anxiety and depression symptom management. Understanding how different substances affect this phase is important for clinical planning and for partners who want to know what to expect.

Alcohol Withdrawal and Anxiety

Alcohol withdrawal is the most medically dangerous of the common withdrawal syndromes. When chronic alcohol use suppresses GABA activity, the brain compensates by downregulating GABA receptors. When alcohol is removed, the suppressed excitatory system rebounds — producing severe anxiety, tremor, sweating, elevated heart rate, and in severe cases, seizures and delirium tremens (DTs).

• 6-24 hours: Early symptoms — anxiety, tremor, nausea, sweating, elevated heart rate and blood pressure, insomnia.
• 12-48 hours: Peak seizure risk. Approximately 5% of patients with severe alcohol use disorder experience withdrawal seizures without pharmacological prophylaxis.
• 48-96 hours: Delirium tremens risk window. DTs involve severe autonomic instability, confusion, and fever, with meaningful mortality risk even with treatment if unmanaged.
• 72-120 hours and beyond: Acute symptoms resolve. Post-acute withdrawal syndrome (PAWS) — persistent anxiety, sleep disruption, dysphoria — may continue for weeks to months.

Alcohol detox requires medical management. Benzodiazepines (diazepam, lorazepam, or chlordiazepoxide) are the standard pharmacological treatment for seizure prevention, administered under CIWA-Ar monitoring. Thiamine (vitamin B1) is given to prevent Wernicke’s encephalopathy. Alcohol withdrawal can be a medical emergency — attempting detox at home without medical supervision carries serious risk.

Opioid Withdrawal and Depression

Opioid withdrawal is not directly life-threatening for otherwise healthy adults, but it is intensely uncomfortable — and the dysphoria, anhedonia, and hopelessness associated with opioid withdrawal can precipitate or worsen existing depression, and in some cases contribute to suicidal ideation.

• 8-24 hours after last use (short-acting opioids): Early symptoms — yawning, watery eyes, runny nose, anxiety, restlessness, insomnia.
• 36-72 hours: Peak symptoms — severe muscle aches, abdominal cramps, diarrhea, vomiting, sweating, elevated heart rate, profound anxiety and dysphoria.
• 5-7 days: Acute withdrawal resolves for most short-acting opioids. Fentanyl withdrawal may follow a longer course due to tissue accumulation.
• Weeks to months: Post-acute withdrawal syndrome (PAWS) — low mood, anhedonia, anxiety, sleep disruption — can closely mimic major depression and requires psychiatric evaluation.

Buprenorphine initiated under COWS monitoring dramatically reduces opioid withdrawal severity and is standard of care under ASAM guidelines. Clonidine, ondansetron, and loperamide address comfort symptoms. Patients with co-occurring depression who are stabilized on buprenorphine can generally begin SSRIs or SNRIs after the acute withdrawal phase.

Stimulant Withdrawal and Mood Disorders

Methamphetamine and cocaine withdrawal is primarily psychiatric rather than pharmacological. There is no equivalent of the GABA rebound seen in alcohol withdrawal. Instead, stimulant withdrawal produces a “crash” of profound fatigue, hypersomnia, and depressed mood in the first 24-72 hours as the dopamine system recovers from extreme overstimulation. An extended depressive phase (1-4 weeks) follows, clinically indistinguishable from major depression and requiring psychiatric evaluation to determine whether it is substance-induced or an independent mood disorder. In heavy methamphetamine users, psychotic symptoms may persist for weeks and require antipsychotic management.

Levels of Care for Dual Diagnosis Couples

The appropriate level of care is determined by the severity of both the substance use disorder and the co-occurring psychiatric conditions, using the ASAM Criteria as the standard framework. For couples, placement decisions also consider the compatibility of each partner’s clinical needs at each stage of care.

Level of Care	Description	Best For
Medical Detox	24/7 medical monitoring; 3-10 days; focused on safe withdrawal management with CIWA-Ar/COWS-guided medication	Physical dependence with seizure or DTs risk; severe opioid withdrawal needing MAT initiation
Residential / Inpatient	24/7 structured programming; 28-90+ days; integrated psychiatric care; couples tracks available at specialized programs	Moderate-to-severe dual diagnosis; unstable home environment; prior failed outpatient attempts
Partial Hospitalization (PHP)	5-6 hours/day, 5 days/week; step-down from residential; psychiatric medication management included	Medically stable but needing intensive psychiatric and addiction care; couples living together
Intensive Outpatient (IOP)	3 hours/day, 3-5 days/week; allows clients to live at home; couples therapy integrated into schedule	Mild-to-moderate dual diagnosis; stable housing and support system
Outpatient Therapy	Weekly individual and couples therapy; ongoing psychiatric medication management	Maintenance and relapse prevention after higher levels of care; stable recovery

For most couples managing anxiety, depression, and addiction together, the clinical recommendation is to begin at the highest appropriate level of care — typically residential or PHP — and step down as stability is established. Attempting outpatient treatment for a severe dual diagnosis often fails because the psychiatric and addiction variables require more monitoring and intervention than weekly sessions can provide.

What Happens During Couples Dual Diagnosis Treatment

Weeks 1-2: Stabilization and Comprehensive Assessment

The first phase of treatment focuses on medical and psychiatric stabilization. For partners with physical dependence, this may include medical detox running concurrently with psychiatric assessment. Each partner undergoes a comprehensive intake evaluation — substance use history, psychiatric history, trauma history, relationship history, medical history, and social supports. The clinical team uses this assessment to develop individualized treatment plans that are coordinated across both partners where joint programming is clinically indicated.

Weeks 3-4: Core Treatment Phase

With stabilization established, full programming begins. Daily schedules typically include individual therapy sessions (CBT, DBT, trauma-focused work), group therapy (psychoeducation, process groups, skill-building), psychiatric medication management appointments, couples sessions, recreational and wellness programming, and peer support meetings. Couples sessions during this phase introduce structured relationship skill work — communication, conflict resolution, identifying enabling and codependency patterns, and building recovery supports together.

Month 2 and Beyond: Deepening Work and Transition Planning

For couples in 60- or 90-day programs, the middle and later phases focus on deeper psychological work, relapse prevention planning, and discharge planning. Continuing care plans are developed collaboratively, identifying the next level of care (PHP or IOP), outpatient psychiatric follow-up, couples therapy, and community recovery supports. Family programming may be offered during this phase where relevant to the recovery plan.

What Happens After Dual Diagnosis Couples Rehab

Residential or inpatient treatment is the beginning of a continuum, not the full recovery plan. Recovery from anxiety, depression, and addiction is a long-term process. The typical continuum for dual diagnosis couples after residential treatment includes:

• Step-down to PHP or IOP for continued intensive dual diagnosis programming
• Outpatient couples therapy to continue the relational work begun in residential treatment — see couples therapy during addiction recovery
• Ongoing psychiatric medication management for anxiety and depression
• Peer support and recovery groups (12-step or SMART Recovery)
• Telehealth therapy options for ongoing mental health and couples counseling — see online couples therapy
• Long-term relapse prevention planning with scheduled check-ins and individualized crisis plans

Couples who engage with continuing care after residential treatment have substantially better long-term outcomes than those who return home without a step-down plan. The transition out of residential treatment is a high-risk period; structured continuing care is a clinical priority for dual diagnosis couples, not an optional add-on.

How to Start the Dual Diagnosis Placement Process Today

1. Call (888) 500-2110. A care navigator will listen to both partners’ situations — confidentially, without judgment, around the clock.
2. Benefits verification. Our team verifies each partner’s insurance coverage for dual diagnosis residential or outpatient treatment at no cost. Coverage is assessed individually; joint placement depends on both partners’ individual clinical needs and program availability.
3. Clinical intake screening. Before placement, each partner undergoes a clinical intake screening to identify the appropriate level of care, confirm that joint placement is clinically indicated, and identify any immediate safety concerns.
4. Placement coordination. Our team coordinates all logistics — paperwork, travel, and the transition from detox to residential programming if needed.
5. Ongoing navigation support. Our care navigators remain available throughout treatment if clinical changes affect the placement plan.

If you have already completed the Couples Assessment, a care navigator will have your results on hand when you call. You can also visit our crisis support page for immediate resources if you or your partner are in acute distress.

Need help right now? If your partner or you are experiencing a psychiatric emergency — suicidal thoughts, active self-harm, or psychosis — call 911 or go to your nearest emergency room immediately. For non-emergency mental health crisis support, call or text 988. For confidential addiction and dual diagnosis placement help, call (888) 500-2110. Couples Rehab is available 24/7.

Frequently Asked Questions

What is dual diagnosis in the context of couples rehab?

Dual diagnosis refers to the simultaneous presence of a mental health disorder — such as anxiety or depression — and a substance use disorder. In couples rehab, one or both partners may carry a dual diagnosis. Integrated dual diagnosis treatment addresses both conditions simultaneously rather than treating addiction and mental health in separate, uncoordinated tracks.

Can anxiety and depression be treated in the same rehab program as addiction?

Yes. Integrated dual diagnosis programs are specifically designed to treat co-occurring anxiety or depression alongside substance use disorders. These programs include psychiatric prescribers, addiction medicine physicians, and licensed therapists who coordinate a unified treatment plan. Treating only the addiction while leaving anxiety or depression untreated significantly increases relapse risk.

Is it safe to detox from alcohol if I also have an anxiety disorder?

Alcohol withdrawal can be dangerous for anyone with daily or heavy drinking patterns, and the overlap with anxiety disorders adds clinical complexity. The rebound anxiety of alcohol withdrawal can be severe, and benzodiazepines used to prevent withdrawal seizures must be managed carefully in patients with co-occurring anxiety to avoid transferring physical dependence. Medical detox with CIWA-Ar monitoring is the safe path — attempting alcohol detox at home without medical supervision carries serious risk regardless of psychiatric history.

How long does couples rehab for anxiety and depression typically last?

Medical detox typically runs 3-10 days. Residential dual diagnosis treatment typically runs 28-90 days, with longer stays associated with better outcomes for more severe dual diagnoses. PHP and IOP step-down programs continue for weeks to months after residential treatment, and outpatient psychiatric and couples therapy continues for as long as clinically indicated.

Does health insurance cover dual diagnosis treatment?

Under the Mental Health Parity and Addiction Equity Act (MHPAEA), most insurance plans must cover mental health and substance use disorder treatment on par with medical and surgical benefits. Dual diagnosis treatment — addressing both conditions — is generally covered under plans that cover mental health or addiction services. Specific benefits, in-network options, and out-of-pocket costs vary by plan and must be verified individually before any commitment is made. Our team verifies benefits at no cost before any commitment is made.

What if only one partner has a mental health diagnosis?

Joint treatment can still be clinically appropriate. Programs can provide individualized psychiatric care for the partner with a formal diagnosis while offering psychoeducation and relational skills work to both partners. Understanding how anxiety or depression affects the relationship — and how to respond skillfully — is valuable for recovery regardless of whether both partners carry a formal psychiatric diagnosis.

What is behavioral couples therapy (BCT) and does it work for dual diagnosis?

BCT is an evidence-based couples-focused addiction intervention that includes a daily sobriety contract, communication skills training, and structured positive activities. Multiple randomized controlled trials show BCT produces better substance use outcomes than individual treatment alone and reduces relationship conflict. Adapted for dual diagnosis, BCT helps partners understand how mental health symptoms affect relationship dynamics so they can support each other’s recovery without enabling substance use.

Can medication for depression or anxiety interfere with addiction treatment?

Most first-line psychiatric medications — SSRIs, SNRIs, buspirone — are compatible with addiction treatment and with MAT for opioid or alcohol use disorder. Benzodiazepines are avoided or used only in carefully controlled medical detox settings for patients with substance use disorders because of their dependence potential. A psychiatric prescriber at a dual diagnosis program manages all medication decisions with both conditions in mind to minimize interaction risk.

What is the difference between substance-induced depression and independent depression?

Substance-induced depression or anxiety arises directly from substance use or withdrawal and generally resolves within days to weeks of sobriety. Independent depression or anxiety disorders exist as separate conditions that require treatment regardless of sobriety status. Clinicians distinguish between these two presentations through careful assessment and observation during the early weeks of treatment — the distinction significantly shapes the treatment plan.

What is CIWA-Ar and why does it matter?

CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) is a validated 10-item scale used to measure the severity of alcohol withdrawal symptoms and guide benzodiazepine dosing to prevent seizures. It is administered repeatedly during medical detox to track symptom progression and adjust medication management in real time.

Is anxiety caused by the relationship itself treatable in couples rehab?

Yes, in many cases. Relational anxiety — anxiety arising from chronic conflict, insecurity, or trauma within the partnership — can be a primary driver of both substance use and mental health symptoms. Couples-focused programming that includes trauma-informed therapy and relational skills work is often more effective for relationship-based anxiety than individual treatment alone, because it can directly address the relational source rather than treating symptoms in isolation.

How do couples know whether they need inpatient versus outpatient treatment for dual diagnosis?

Level-of-care decisions are made through clinical assessment using the ASAM Criteria, which evaluates acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment. Generally, more severe psychiatric symptoms, physical dependence requiring medical detox, or an unstable home environment point toward inpatient care. A clinical intake screening with our team can help identify the right level of care for each partner.

Does anxiety or depression increase the risk of relapse after addiction treatment?

Yes. Untreated or undertreated anxiety and depression are among the strongest predictors of relapse after addiction treatment. This is why integrated dual diagnosis treatment — addressing both conditions simultaneously — consistently produces better long-term outcomes than addiction-only treatment. Ongoing psychiatric care after discharge is a key component of relapse prevention for dual diagnosis clients.

What happens if one partner refuses to go to rehab?

Joint treatment requires both partners to voluntarily participate. If one partner is not ready, the other can still begin treatment and benefit significantly. Programs can work with the attending partner individually and support a structured conversation when the reluctant partner is ready to reconsider. See also how to convince your partner to go to rehab.

What should couples bring to inpatient dual diagnosis rehab?

Programs provide specific packing lists at admission, but generally: comfortable clothing, prescription medications in original labeled bottles for verification, any relevant medical or psychiatric records, government-issued ID, and insurance cards. Policies on personal electronics and other items vary by program and should be confirmed directly with the admitting facility before arrival.

How can we get started today?

Call (888) 500-2110 to speak with a care navigator. We are available 24 hours a day, seven days a week. Our team will listen to your situation, verify insurance benefits at no cost, and identify dual diagnosis programs with availability that can serve both partners. You can also begin with the Couples Assessment online.

Trusted Sources

• SAMHSA: Substance Abuse and Mental Health Services Administration
• NIDA: Comorbidity — Substance Use Disorders and Other Mental Illnesses
• NIMH: Depression
• NIMH: Anxiety Disorders
• NIAAA: National Institute on Alcohol Abuse and Alcoholism
• ASAM: Clinical Practice Guidelines
• 988 Suicide and Crisis Lifeline

Editorial Disclaimer: Couples Rehab is a national addiction treatment placement and referral network, not a treatment facility. This content is written for informational purposes only and does not constitute medical or psychiatric advice. Dual diagnosis treatment recommendations are made through individual clinical assessment by licensed providers — not determined by this article. Insurance coverage for dual diagnosis treatment is verified individually before any commitment is made; coverage outcomes cannot be guaranteed. If you or your partner are experiencing a psychiatric emergency, call 911 or go to the nearest emergency room. For crisis support, call or text 988. Always consult a qualified clinician before making treatment decisions.